Antibodies
8 November 2013
INNATE PHARMA: Launch of IND-Enabling studies for IPH41027 November 2013
Bayer Submits VEGF Trap-Eye (aflibercept solution for injection) for Treatment of Diabetic Macular Edema in the EU6 November 2013
Emergent BioSolutions Presents Preclinical Data on ES414, Its Lead Bispecific ADAPTIR Therapeutic for Prostate Cancer5 November 2013
ImmunoGen, Inc. Announces Discontinuation of IMGN901 Study in Small-Cell Lung Cancer (SCLC)5 November 2013
Theraclone Sciences’ Monoclonal Antibody Candidate PGT121 Suppresses HIV in Simian Models of Disease4 November 2013
GeNeuro Successfully Completes Phase 2a Clinical Study with Novel Approach to Treat Multiple Sclerosis1 November 2013
FDA Approves Gazyva™ (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)31 October 2013
Results From Two Phase 2 Studies in XOMA’s Gevokizumab Proof-of-Concept Program Are Very Encouraging and Compelling31 October 2013
ABLYNX ANNOUNCES UPDATE ON ANTI-RSV NANOBODY PROGRAMME AND RECEIVES GRANT FUNDING FOR FURTHER DEVELOPMENT29 October 2013
RSV Vaccines for the World 2013 Conference Presentation Highlights Data from ADMA Biologics’ Human and Animal Study ExperienceNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports